These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10530 related articles for article (PubMed ID: 12617778)

  • 1. Antisense candidates against protein kinase C-alpha designed based on phylogenesis and simulant structure of mRNA.
    Song HF; Tang ZM; Yuan SJ; Zhu BZ; Liu XW
    Acta Pharmacol Sin; 2003 Mar; 24(3):269-76. PubMed ID: 12617778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of secondary structure prediction in antisense drug design targeting protein kinase C-alpha mRNA and QSAR analysis.
    Song HF; Tang ZM; Yuan SJ; Zhu BZ
    Acta Pharmacol Sin; 2000 Jan; 21(1):80-6. PubMed ID: 11263253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of antisense drug design against conservative local motif in simulant secondary structures of HER-2 mRNA and QSAR analysis.
    Yang SP; Song ST; Tang ZM; Song HF
    Acta Pharmacol Sin; 2003 Sep; 24(9):897-902. PubMed ID: 12956938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Target secondary structural motif" in the action of antisense oligodeoxynucleotides].
    Song HF; Tang ZM
    Yao Xue Xue Bao; 2001 Aug; 36(8):585-9. PubMed ID: 12579934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
    Dean N; McKay R; Miraglia L; Howard R; Cooper S; Giddings J; Nicklin P; Meister L; Ziel R; Geiger T; Muller M; Fabbro D
    Cancer Res; 1996 Aug; 56(15):3499-507. PubMed ID: 8758918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of STAT3 antisense oligodeoxynucleotides on apoptosis and proliferation of mouse melanoma cell line B16].
    Tang GS; Cai JM; Ni J; Xiang YS; Cui JG; Zhu D; Dong JR
    Ai Zheng; 2006 Mar; 25(3):269-74. PubMed ID: 16536977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice.
    Geiger T; Müller M; Dean NM; Fabbro D
    Anticancer Drug Des; 1998 Jan; 13(1):35-45. PubMed ID: 9474241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
    Miyake H; Chi KN; Gleave ME
    Clin Cancer Res; 2000 May; 6(5):1655-63. PubMed ID: 10815883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense expression of protein kinase C alpha improved sensitivity to anticancer drugs in human lung cancer LTEPa-2 cells.
    Wang XY; Liu HT
    Zhongguo Yao Li Xue Bao; 1998 May; 19(3):265-8. PubMed ID: 10375741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of interleukin-6 on the growth of human lung cancer cell line.
    Fu J; Zheng J; Fang W; Wu B
    Chin Med J (Engl); 1998 Mar; 111(3):265-8. PubMed ID: 10374431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of bcl-2 antisense oligodeoxynucleotides on growth of human lung carcinoma xenograft in nude mice].
    He DM; Zhang H
    Ai Zheng; 2006 Jan; 25(1):40-4. PubMed ID: 16405747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
    Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
    Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligodeoxynucleotides downregulated c-sis mRNA expression to inhibit proliferation of vascular smooth muscle cells.
    Tang QD; Lin SG; Yu XY
    Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):36-42. PubMed ID: 10437122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
    Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotide Elk-1 suppresses the tumorigenicity of human hepatocellular carcinoma cells.
    Ying TH; Hsieh YH; Hsieh YS; Liu JY
    Cell Biol Int; 2008 Feb; 32(2):210-6. PubMed ID: 17950002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].
    Zhou Q; Bai M; Su Y
    Ai Zheng; 2005 Feb; 24(2):149-54. PubMed ID: 15694023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS; Clement JJ
    Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 527.